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Abstract
System xc- exchanges extracellular cystine for intracellular glutamate across the plasma membrane
of many cell types. One of the physiological roles of System xc- is to provide cystine for synthesis of the
antioxidant glutathione. Here we report that hydrogen peroxide (H2O2) triggers the translocation of System
xc- to the plasma membrane within 10 min of the initial exposure. Specifically, we observed a three-fold
increase in 35S-L-cystine uptake following a 10 min exposure to 0.3 mM H2O2. This effect was dosedependent with an EC50 for H2O2 of 65 µM. We then used cell surface biotinylation analysis to test the
hypothesis that the increase in activity is due to an increased number of transporters on the plasma
membrane. We demonstrated that the amount of transporter protein, xCT, localized to the plasma
membrane doubles within 10 min of H2O2 exposure as a result of an increase in its delivery rate and a
reduction in its internalization rate. In addition, we demonstrated that H2O2 triggered a rapid decrease in
total cellular glutathione which recovered within two hours of the oxidative insult. The kinetics of
glutathione recovery matched the time course for the recovery of xCT cell surface expression and System
xc- activity following removal of the oxidative insult. Collectively, these results suggest that oxidants
acutely modulate the activity of System xc- by increasing its cell surface expression, and that this process
may serve as an important mechanism to increase de novo glutathione synthesis during periods of
oxidative stress.
Key Words: Cystine/glutamate exchanger, neurotransmitter transporter, membrane trafficking, oxidative
stress, glutathione, ischemia
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Abbreviations:
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
BSA bovine serum albumin
CPG S-4-carboxyphenylglycine
DAT Dopamine tranporter
DCFH-DA 2',7'-dichlorodihydrofluorescein diacetate
DEM dietyhlmaleate
DS donkey serum
EEA1 early endosome antigen
EAAC1excitatory amino acid carrier 1
EAAT excitatory amino acid transporters
ENaC epithelial sodium channel
EV empty vector
FBS fetal bovine serum
GABA γ-aminobutyric acid
GAT1 γ-aminobutyric acid transporter 1
HAAT heterodimeric amino acid transport
H2O2 Hydrogen peroxide
Nrf2 Nuclear factor erythroid 2-related factor 2
PBS Phosphate buffered saline
RIPA Radioimmunoassay
SDS Sodium dodecyl sulfate
TfR Transferrin receptor
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1. Introduction
Cells utilize several antioxidant defense systems to counteract the reactive oxygen intermediates
that are by-products of normal cellular metabolism (see Sies, 1997 for review). Without these systems, the
reactive oxygen species would rapidly damage cellular lipids, proteins, and DNA, leading to oxidative
stress and eventually cell death. Glutathione is a tripeptide composed of glutamate, cysteine and glycine
and is one of the most important small molecule antioxidants. Glutathione is typically maintained in
millimolar concentrations with cells. As such, depletion of cellular glutathione levels rapidly leads to
oxidative stress, and if severe, oxidative cell death (Sies, 1997). Thus, it is not surprising that disorders in
glutathione metabolism are associated with many neurodegenerative diseases (see Aoyama and Nakaki,
2013 for review).
System xc- is a membrane transport system that plays a significant role in maintenance of cellular
glutathione levels and protection from oxidative stress (Kato et al., 1993, 1992a; McBean, 2002; Sato et
al., 2000). Specifically, System xc- is a Na+-independent, Cl--dependent transporter which exchanges
extracellular cystine for intracellular glutamate (Bannai and Kitamura, 1980; Patel et al., 2004) in the
meninges, and astrocytes in many regions of the brain (including the cortex, hippocampus, cerebellum,
and the striatum). It is also active in the duodenum and kidney (Burdo et al., 2006; Chase et al., 2001;
Pow, 2001; Shih and Murphy, 2001). In these tissues, cystine, which is internalized by System xc-, is
rapidly reduced to cysteine, the rate limiting reagent for the synthesis of glutathione (Lu; McBean, 2012).
As such, pharmacological inhibition of System xc- in cultured cells results in decreased cellular glutathione
levels, the development of oxidative stress and cell death (Albrecht et al., 2010; Kato et al., 1992a;
Murphy et al., 1990; Pereira and Oliveira, 1997). Furthermore, decreases in System xc- expression are
associated with loss of glutathione and an increase in oxidative stress (Carpi-Santos et al., 2015;
Nabeyama et al., 2010; Sato et al., 2005; Shih et al., 2006a), and induction of System xc- in cell cultures
leads to increases in intracellular glutathione levels and greater protection from oxidative stress (Miyazaki
et al., 2016; Shih et al., 2006b). In turn, the redox environment of the cell appears to regulate the basal
level of System xc- expression. For example, chronic exposure of cultured cells to oxidative agents or
glutathione synthesis inhibitors leads to increased System xc- expression over the course of 24 hours
(Bannai, 1984; Miura et al., 1992; Ruiz et al., 2003; Sato et al., 2001). This process has been shown to be
a result of Nrf2-mediated transcriptional activation of xCT, one of two subunits that comprise System xc(Bannai and Ishii, 1982; Ishii et al., 2000; Sasaki et al., 2002; Shih et al., 2003).
Despite the fact that System xc- plays such a pivotal role in regulating glutathione synthesis, the
short-term regulation of System xc- by oxidants is not understood. However, System xc- activity has been
shown to increase within minutes of onset of ischemia in synaptic membrane fractions (Koyama et al.,
1995), mixed cortical cell cultures (Fogal et al., 2007), cortical brain slices and in vivo in the cortex and
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striatum (Soria et al., 2014). These data suggest that oxidants may acutely regulate System xc- activity,
thereby providing a rapid mechanism by which cells may increase cystine import and glutathione
synthesis prior to Nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated transcriptional upregulation
of System xc- expression. In the present study, we sought to characterize the acute regulation of
endogenously expressed System xc- by hydrogen peroxide (H2O2) in cultured human astrocytoma cells (U138MG). We chose to study cultured astrocytes specifically given that 1) System xc- is primarily
expressed in astrocytes in the brain and 2) astrocytes play a central role in controlling neuronal glutathione
levels. Thus, astrocytes represent an excellent system for addressing questions related to the acute
regulation of System xc- by oxidants. Our results indicate that H2O2 triggers the rapid trafficking of
endogenously expressed System xc- to the cell surface, resulting in a three-fold increase in cystine uptake
within 10 min of H2O2 exposure. Moreover, we demonstrated that the kinetics of increased cystine
transport and cell surface expression match the kinetics of the recovery of intracellular glutathione
following acute hydrogen peroxide exposure. Therefore, these findings suggest that the acute regulation
of System xc- trafficking may serve as an important component of the defense arsenal utilized by glial cells
to maintain cellular glutathione levels following an oxidative insult.

A portion of this work has

previously been presented in poster form (Goltz et al., 2008; Sheldon et al., 2006).
2. Experimental Procedures
2.1 Cell Culture. Human glioma U-138MG cells were maintained in Minimum Essential
Medium supplemented with 10% fetal bovine serum (FBS), 1% sodium pyruvate, 1% non-essential amino
acids solution, and 1% penicillin/streptomycin in 100-mm dishes. COS-7 cells were maintained in
Dulbecco’s Modified Eagle Medium supplemented with 4 mM L-glutamine, 4500 mg/L glucose, 1 mM
sodium pyruvate, 1500 mg/L NaCO3, 10% FBS and 1% penicillin/streptomycin in 100-mm dishes.
Medium was changed every two or three days, and cultures were split 1:6 every 6-8 days. U-138MG cells
and COS-7 cells were obtained from the American Type Culture Collection. Tissue culture media and
chemicals were purchased from Life Technologies.
2.2 Human myc-xCT and HA-CD98 constructs: Human xCT was cloned into pCR2.1 using the
TA Cloning Kit (Invitrogen) and sub-cloned into pCMV-3Tag-2A (Clonetech) vector at the
EcoR1/HindIII site by adding EcoR1 and HindIII restriction sites to the full length xCT cDNA using
appropriate primers with PCR. Human CD98 was initially cloned into pCR2.1using the TA Cloning Kit
(Invitrogen) and later subcloned into pCMV-HA-N (Clonetech) at the EcoR1/NotI site by adding EcoR1
and NotI restriction sites to the full length cDNA using appropriate primers with PCR. Insertion of
human xCT and human CD98 was confirmed using restriction digest analysis followed by complete DNA
sequencing of the inserts and vector cloning site.
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2.3 Heterologous expression of human myc-xCT and HA-4F2HC in COS-7 cells: Transfectionquality cDNA was produced using the Pure Yield Plasmid Midi-prep system (Promega). myc-xCT and
HA-4F2HC were co-transfected into COS-7 cells using Lipofectamine 2000 (Life Technologies). Six
hours later the media was replaced with antibiotic-free and FBS-free media which was maintained for 2448 hours prior to the initiation of cell surface biotinylation assays.
2.4 Development of anti-xCT antibody. System xc- belongs to a family of heterodimeric amino
acid transport (HAAT) proteins (SLC7a11) that includes nine different members ( for review see
Chillarón et al., 2001; Palacín and Kanai, 2004). Like all members of the HAAT family, System xcrequires the expression of two proteins, a 50 kD light chain protein (xCT) that is linked through a disulfide
bond to a 98 kD type II glycosylated heavy chain protein, 4F2HC (also named CD98, FRP-1, and
SLC3A2) (Sato et al., 2000, 1999). Polyclonal anti-peptide antibodies were generated against the proteinconjugated synthetic peptide (KPVVSTISKGGYLQG) in rabbit corresponding to amino acids 3-18 in the
N-terminal region of xCT, and the antibodies were affinity purified from the crude antiserum using
methods previously described (Rothstein et al., 1994; F uruta et al., 1997).
The specificity of the newly developed anti-xCT antibody was initially tested on cell lysates
prepared from the cultured human glioma cell line, U-138MG, which exhibits a high level of endogenous
System xc- activity (Ye et al., 1999). Western blot analysis of U-138MG cell lysates with anti-xCT
antibody yielded a prominent band at 40 kD band, similar to the immunoreactivity observed by Sieb, et al.
(Seib et al., 2011) (Figure 1A). We examined the specificity of the antibody by two methods. Since xCT
protein expression and System xc- activity have been reported to be upregulated by exposure of cultured
cells to oxidizing agents (Bannai, 1984; O’Connor et al., 1995; Sato et al., 1998), we examined xCT
expression in U-138 MG cells treated with 0.1 mM diethylmaleate (DEM) for 24 hours.
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transport doubled following DEM treatment, increasing from 58 ±9 pmols/mg protein/min under baseline
conditions to 128 ± 7 pmols/mg protein/min). We also observed a doubling of the immunoreactivity of
the 40 kD band as expected following DEM treatment and the appearance of less intense bands at 27 kD,
95 kD (potential xCT multimer) and 135 kD (xCT:CD98 dimer), similar to those detected with other xCT
antibodies (Burdo et al., 2006) (Figure 1a). In addition, we also overexpressed 3Xmyc-xCT in COS-7
cells and performed a biotinylation assay to separate membrane proteins from intracellular proteins. We
then probed for xCT with the anti-xCT antibody. We only observed one band near 43 kD band in mycxCT transfected cells, but not in empty vector (EV) transfected cells when probed with the anti-xCT
antibody (Figure 1B). Given that the molecular weight of the myc tag is 1.2 kD, the addition of a 3X
myc-tag to xCT would be expected to produce a 43.6 kD band. To confirm that this band corresponded
to myc-xCT and to ensure that the protein was expressed both intracellularly and on the membrane as one
would expect for System xc-, we transfected COS-7 cells with either myc-xCT or EV and performed a cell
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surface biotinylation assay prior to Western blot analysis. When probed with anti-myc antibody, again
only one specific band at 43 kD was also observed in both the intracellular and membrane fractions from
myc-xCT transfect cells, while only the appearance of a non-specific (NS) band was observed in the
intracellular fraction of the EV-transfected cells (Figure 1C). (We subsequently used this NS as a protein
loading control and to confirm separation of membrane and intracellular fractions.) Finally, the newly
developed xCT antibody (1:50) was also tested for its use in immunocytochemistry applications in COS-7
cells transfected with the myc-xCT construct (Figure 1D). After fixation, permeabilization, and blocking
in PBS with 5% Donkey Sera (PBS/DS), COS-7 cells were treated with primary antibodies rabbit antixCT (1:50) and mouse anti-myc (1:100; Santa Cruz Biotechnology 9E10) overnight at 4oC. Cells were
washed 3 times with PBS/DS and then incubated with FITC-conjugated donkey anti-rabbit IgG and
Alexa-Fluor 542 conjugated donkey anti-goat IgG (1:100) for 2 hours (Jackson ImmunoResearch). We
observed that xCT expression is punctate and appears to be distributed between the plasma membrane and
intracellular compartments as we demonstrated in our cell surface biotinylation analysis (Figure 1C). In
addition, we only observe green immunostaining in myc-xCT transfected COS-7 cells which co-localizes
with red immunostaining for the myc epitope (Figure 1D). Given that the primary antibodies for myc and
and xCT were generated in different species and that the Pearson Correlation coefficient indicates strong
colocation between myc and xCT immunostaining (0.979), we are confident that the newly developed
anti-xCT antibody specifically reacts with xCT and does not exhibit any non-specific binding.
2.5 Biotinylation of cell surface proteins. Biotinylation of cell surface proteins was performed
using a method that was adapted from Fournier, et al. (Fournier et al., 2004) and Loder, et al. (Loder and
Melikian, 2003). U-138MG cells or COS-7 cells were grown to 90% confluence in 35 mM dishes and
were serum-starved for 24 hours prior to the experiment to synchronize them in the G0/G1 phase of the cell
cycle. Serum-starved cells were treated with the indicated dose of H2O2 (Sigma) or pre-warmed culture
medium (vehicle) and placed back in the incubator for 10 min. Plates were then removed, placed on ice
and rinsed twice with ice-cold phosphate buffered saline (PBS) with 1 mм magnesium and 0.1 mм
calcium (PBS-Ca/Mg). The plates were gently rotated at 4°C for 60 minutes in 0.5 ml of membraneimpermeant biotinylation solution (EZ link Sulfo-NHS-Biotin, 1 mg/ml in PBS-Ca/Mg, Pierce, Rockford,
IL). The biotinylation solution was aspirated, the plates were rinsed twice with ice-cold PBS-Ca/Mg with
100 mм glycine (Sigma, St. Louis, MO), and incubated with 1 ml of PBS-Ca/Mg with glycine for 25
minutes at 4°C with gentle shaking. Next, the plates were rinsed twice with ice-cold PBS-Ca/Mg, and 0.3
ml of radioimmunoprecipitation assay (RIPA)/lysis buffer with protease inhibitors (150 mм NaCl, 1 mм
EDTA, 100 mм Tris-HCl, pH 7.4, 1% Triton-X, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate
(SDS), 1 µg/ml leupeptin, 250 µм PMSF, 1 µg/ml aprotinin, 1 mм iodoacetamide; all chemicals from
Sigma, St. Louis, MO) was added to the plates and rotated for 1 hour at 4°C to lyse the cells.
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The lysates were transferred to microcentrifuge tubes and centrifuged at 12,400 rpm for 20 minutes at
4°C. Aliquots of the lysate were taken for protein concentration analysis (BCA Protein Assay Kit, Pierce)
and for Western blot analysis (“lysate” fraction). Aliquots of lysate were added to equal volumes of
avidin bead suspension (100 µl of lysate in 100 µl of Ultralink Immobilized Monomeric Avidin, Pierce).
The avidin-lysate solution was rocked overnight at 4°C, and subsequently centrifuged at 12,400 rpm for
15 minutes. A sample of the supernatant was taken for Western blot analysis (“intracellular” fraction).
The avidin beads were resuspended in RIPA/lysis buffer with protease inhibitors and centrifuged at 12,400
rpm for 5 minutes. The supernatant was discarded, and the beads were washed twice in 0.3 ml of high
salt-wash buffer (0.1% Triton X-100, 500 mм NaCl, 5 mм EDTA, 50 mм Tris, pH 7.5) and once in 0.3 ml
of no salt-wash buffer (50 mм Tris, pH 7.5). The beads were incubated in 2X sample buffer for 10
minutes at room temperature and 30 minutes at 37°C, and subsequently centrifuged at 12,400 rpm for 5
minutes. A sample of the supernatant was saved for Western blot analysis (“membrane” fraction). All of
the samples taken for Western blot analysis were stored in equal volumes of sample buffer (4% SDS, 120
mM Tris, 0.02% bromophenol blue, 20% glycerol, 2% β-mercaptoethanol, pH 6.8) and frozen at -20°C.
2.6 Delivery of xCT to the plasma membrane. Biotinylation of cell surface proteins was
completed under trafficking-permissive conditions using an adaptation of the methods used to measure the
constitutive delivery rate the Na+-dependent glutamate transporter, EEAC1 (Fournier et al., 2004) and the
γ-aminobutyric acid (GABA) transporter, GAT1 (Wang and Quick, 2005). Cultured U-138MG cells
grown to 90% confluence in 35 mM plates and serum-starved for 24 hours. Cells were washed two times
in PBS-Ca/Mg pre-warmed to 37oC and treated with 0.5 mL of pre-warmed biotinylation solution at 37oC
for the indicated period of time. In some experiments, 0.3 mM H2O2 in PBS was added for 10 min and
washed prior to adding the biotinylation solution for the indicated time. The biotinylation solution was
then aspirated and cells were rinsed two times in ice-cold PBS-Ca/Mg containing glycine to terminate
protein trafficking. Biotinylated proteins were subsequently separated from intracellular proteins as
describe above.
2.7 Western blot. Each fraction (lysate, intracellular and membrane) from the biotinylation
experiments was electrophoresed on a 4-12% SDS-polyacrylamide gel (Invitrogen) and transferred to a
nitrocellulose membrane (GE Amersham) at 25 volts for 2 hours. The membranes were blocked with 5%
bovine serum albumin (BSA) protein in TBS with 0.05% Tween -20 (TBS-T) for 1 hour. The membranes
were probed with rabbit anti-xCT (1:400), mouse anti-CD98 (1:200) (Abcam), or rabbit anti-actin
(1:5,000) (Sigma) in 5% BSA in TBS-T (0.1%) in overnight. The membranes were washed in TBS-T
(0.05%) 4 times for 10 minutes each time and incubated with the appropriate horseradish peroxidaseconjugated goat secondary IgG diluted 1:50,000 in 5% BSA in TBS-T (0.1%). The membranes were
washed 4 times for 10 minutes each time in TBS-T (0.05%) and visualized using Lumigen TMA-6
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(Lumigen) and Kodak BioMax Light Film or digitally using a UVP Bio-Chemi Gel Documentation
System.
2.8 ELISA Assay for Internalization of xCT from the plasma membrane. The internalization
kinetics of xCT were measured using an adaptation of an ELISA-based assay previously described to
study internalization rates of many different types of receptors, including α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors (Lin et al., 2000; H. Y. Man et al., 2000), α-adrendergic
receptors (Wang et al., 2007) and epidermal growth factor receptors (Johns et al., 2002). U-138MG cells
were grown to 90% confluence in 12-well dishes, serum-starved for 24 hours, and washed two times with
ice-cold PBS-Ca/Mg to halt protein trafficking. Cell surface xCT proteins were labeled by treating cells
with PBS-Ca/Mg containing an anti-xCT antibody directed to an extracellular region of the protein
(SCBT, Q-18, 10 µg/mL, raised in goat) at 4oC for 1 hour. The cells were then washed two times in icecold PBS Ca/Mg, warmed to 37oC (trafficking permissive conditions) and treated with either saline or 0.3
mM H2O2 for the indicated period of time. The cells were fixed for 5 min with 2% paraformaldehyde in
PBS, washed two times with PBS, and treated with a horseradish peroxidase-conjugated donkey-anti goat
antibody (Jackson Immuno, 1:1000) for 1 hour. Finally, the cells were washed two more times with PBS
and treated with chromogenic substrate (OPD, Sigma), for 2 min and the reaction was quenched with 0.2
volumes of 3 N HCl. The absorbance at 492 nm of each sample was then measured. The relative
internalization was calculated by dividing the absorbance of each sample by the average absorbance
measured in samples which were assayed immediately following the second wash step to remove the
primary antibody, i.e. samples in which the temperature was not raised to trafficking-permissive
conditions following primary antibody treatment (n=6).
2.9 Measurement of Intracellular H2O2. U-138MG cells were grown to 95% confluence in 96-well
plates and serum starved for 24 hours prior to the initiation of the assay. Cells were treated with 100 µM
cell permeable 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA, Sigma) for 1 hour in serum-free
culture medium. The cells were washed with PBS and treated with 0.3 mM H2O2 or an equal volume of
PBS for 10 min and then washed with PBS. The fluorescence emission (529 nm; excitation 495 nM) in
each well was monitored every 2 minutes for a total of 2 hours before, during and following H2O2 or PBS
treatment. The fraction initial emission was calculated for each well at each time point (fraction baseline
DCF signal = emission at time x – emission at time 0) / emission at time 0).
2.10 Immunocytochemistry. U-138MG cells were grown to 95% confluence on cover slips and
were fixed with 3% paraformaldehyde in PBS containing 5% donkey sera (PBS/DS) for 15 min and
permeabilized for 5 min with 0.1% Triton-X in PBS/DS. Cells were incubated with primary antibody for
anti-xCT (1:50) and/or anti-early endosome antigen (EEA1) (1:100; mouse polyclonal, BD Biosciences)
or anti-CD98 (goat polyclonal from Abcam, 1:100) overnight at 4°C. Cells were washed 3 times with
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PBS/DS and then incubated with FITC-conjugated donkey anti-rabbit IgG and/or Alexa-Fluor 542
conjugated donkey anti-goat IgG (1:100) for 2 hours (Jackson ImmunoResearch) at 4oC. The cells were
washed four times with PBS for 10 min and the coverslips were mounted on slides with ProLongGold
(Life Technologies) and prepared for viewing. Slides were viewed using a Zeiss Axiovert 200M
fluorescence microscope with an ECPlanNeoFlura 100X objective (1.3 N.A.) with ApoTome for
deconvolution. Images were captured using a AxioCam MRM camera and Axiovision software. Pearson
coefficient measurements and were performed using NIS Elements Imaging Software Version 4.13. For
whole cell co-localization measurements, the entire cell was identified as a region of interest (ROI). For
examining the membrane co-localization, ROI were measured along 20-pixel width band along the
periphery of the cell.
2.11 Uptake Assays U-138MG cells or COS-7 cells were plated in 12-well dishes and allowed to
grow to 90-95% confluence. Cells were serum-starved for 24 hours prior to the assay. Cells were treated
with fresh, serum-free culture medium containing the indicated concentration of H2O2 for 10 minutes prior
to the uptake assay. The control cells were treated with fresh, serum-free culture medium without H2O2.
The cells were then washed three times with PBS at 37oC. Cells were treated with the indicated
concentration of L-cystine containing 35S-L-cystine (0.5 µCi/mL) (GE Amersham) for 2 minutes in the
presence and absence of the competitive System xc- non-transportable inhibitor, S-4-carboxyphenylglycine
(CPG) (Tocris). The cells were washed three times with ice-cold PBS and then solubilized with 0.1 M
sodium hydroxide. A portion of the sample was combined with CytoScint (Fisher Scientific) and
analyzed using a scintillation counter. A second portion of the sample was used to measure the protein
content of the sample using the BCA Protein Assay Kit (Pierce, Grand Island, NY). Each sample was
then normalized to total protein content.
2.12 Glutathione Analysis Cultured U183MG cells were grown to 95% confluence on 20 mm
culture plates. At time zero, the cell culture medium was removed and cells were treated with warmed
culture medium containing 0.3 mM H2O2 for 10 min or warmed cell culture medium lacking H2O2
(control). After the 10 minute incubation, the culture medium from treatment and control plates was
removed and fresh, warmed culture medium was added back to the plates. The plates were placed back in
the incubator, and glutathione levels in the cells were then measured as described below at the indicated
times.
The cells were washed with 1 mL of PBS, and 200 µL of 10 mM HCl was added and the plates
were scraped. The cell suspension was transferred to a microcentrifuge tube and subjected to three cycles
of freeze/thaw in liquid nitrogen. A 50 µL aliquot was removed for measurement of protein content.
the remaining sample, 5% of metaphosphoric acid (Sigma) was added to deproteinate the sample. The
sample was centrifuged and triethanolamine (Sigma) was added to the supernatant to neutralize the
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To

sample. Total cellular glutathione was measured using an adaptation of the procedure developed by
Tietze (Tietze, 1969). Each sample was then normalized to total protein content.
2.13 Trypan Blue Cell Survival Assay Cultured U183MG cells were grown to 95% confluence in
12-well plates. Cells were removed from the plate using 0.025% trypsin/ 0.01% EDTA, pelleted and resuspended in 100 µL of PBS. The cell suspension was combined in a 1:1 ratio with 0.4% Trypan blue
(Sigma, mixed and then added to a hemocytometer. Blue cells (dead) and clear cells (living) were counted
in the four large cells in the hemocytometer and the percent living cells was calculated.
3. Results
3.1 Effects of H2O2 on L-[35S]-cystine uptake and L-[3H]-glutamate uptake
As previously mentioned, the expression of System xc- is regulated by the redox state of the cell
(Bannai, 1984; Miura et al., 1992; Ruiz et al., 2003; Sato et al., 2001). Recent in vitro and in vivo studies
have demonstrated that System xc- activity is induced within hours of exposure to oxidative agents (32) or
onset of hypoxia/ischemia (Fogal et al., 2007; Mysona et al., 2009). However, the acute regulation of
transporter activity by oxidative agents has not been studied. Therefore, we sought to determine if a brief
exposure of oxidants to cultured cells could trigger a rapid change in System xc- activity independent of an
increase in transporter expression.
We found a 10 min exposure of confluent cultured human glioma cells (U-138MG) to 0.3 mM
H2O2 resulted in an immediate three-fold increase in 35S-L-cystine transport (t(22)=-3.81, p<0.001), with
no significant change in the non-specific cystine transport (Figure 2A; t(17)=0.12, p=0.9)). This effect of
H2O2 was dose dependent with an EC50 of 65 µM H2O2 (Figure 2B) and did not return to baseline until
120 min following removal of the oxidant from the medium (Figure 2C). Kinetic analysis of cystine
transport indicated that 0.3 mM H2O2 caused a nearly two-fold increase in the Vmax of cystine transport
(from 297 ± 58 pmols/mg protein/min to 513 ± 58 pmols/mg protein/min), with a little change in the
observed Km (100 µM compared to 117 µM, respectively, Figure 2D).
3.2 Effects of H2O2 on cell surface expression of System xcThe fact that we observed a doubling of the Vmax of 35S-L-cystine transport within ten minutes of
H2O2 exposure suggests that H2O2 1) rapidly increases the rate of de novo synthesis of xCT, 2) increases
the cell surface expression of the System xc- and/or 3) modifies the transporter in such a way to increase its
basal catalytic rate. Given that several transporters, including the excitatory amino acid transporters
(EAATs) (Robinson, 2006; Santos et al., 2009), monoamine transporters (Melikian, 2004), GABA
transporters (Wang and Quick, 2005) and glucose transporter (GLUT4) (Hou and Pessin, 2007), are
known to undergo rapid regulated membrane trafficking to and from the cell surface in response to various
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stimuli, we sought to test the hypothesis that H2O2 triggers the translocation of System xc- from
intracellular compartments to the plasma membrane.
System xc- belongs to the family of HAAT proteins that includes nine different members with
unique amino acid substrate specificities (for review see Ye et al., 1999). Like most members of the
HAAT family, System xc- is composed of two proteins, a 50 kD light chain protein (xCT) that is linked
through a disulfide bond to a 98 kD type II glycosylated heavy chain protein, 4F2HC (also named
CD98hc, FRP-1, and SLC3A2) (Sato et al., 2000, 1999). Since the xCT light chain confers the transport
activity of System xc-, we first examined the membrane localization of xCT in U-138MG cells using a cell
surface biotinylation assay. In confluent U-138MG cells, only 34 ± 3% of xCT is localized to the plasma
membrane (Figure 3A), similar to other transport systems that undergo regulated trafficking to and from
the cell surface (Fournier et al., 2004; Loder and Melikian, 2003; Staub et al., 2000; Wang and Quick,
2005). After exposure of glioma cells to 0.3 mM H2O2 for 10 min, however, there is a statistically
significant shift in xCT localization to the plasma membrane ((Figure 3A and 3C; t(14)=-4.072;
p<0.001)). The total xCT immunoreactivity measured in the lysate fraction does not increase as a result of
H2O2 treatment (1.07 ± 0.15-fold change compared to control (t(7)=0.472; p=0.651)) confirming that
H2O2 does not increase the de novo expression of xCT. In addition, actin is not visible in the biotinylated
fraction in H2O2 treated samples, demonstrating that the H2O2 treatment does not compromise the integrity
of the membrane (Figure 3A).
Previous studies have suggested that 4F2HC functions to regulate the trafficking of light chains
which belong to the HAAT family. Therefore, we sought to measure the changes in 4F2HC trafficking in
response to H2O2. Similar to xCT, a small fraction of 4F2HC is observed on the membrane in confluent
U-138MG cells, however, 4F2HC does not undergo a comparable shift to the membrane in H2O2 treated
cells (Figure 3B and 3C; t(6)=-0.235; p=0.822)). Thus, our data suggest that either H2O2 does not trigger
a shift in membrane localization of 4F2HC following H2O2 or that only a small fraction of 4F2HC traffics
to the membrane in response to H2O2 which is below the detection limit of our biotinylation assay.
3.3 Effect of H2O2 on the trafficking of xCT
Many plasma membrane proteins have been shown to recycle rapidly on the plasma membrane
including, but not limited to the GLUT4, epithelial sodium channel (ENaC), dopamine transporter (DAT),
transferrin receptor (TfR), and the neuronal Na+-dependent glutamate transporter (EAAC1) (Butterworth
et al., 2009; Fournier et al., 2004; Hou and Pessin, 2007; Loder and Melikian, 2003; Trowbridge, 1991).
The steady state level of a plasma membrane protein is controlled by 1) the rate of its delivery (from either
the biosynthetic pathway or recycling endosomes) to the plasma membrane and 2) the rate of its recovery
(through the process of endocytosis) from the plasma membrane. Therefore, we sought to determine
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whether the H2O2-induced rise in membrane localization of xCT was a result of an increase in the rate of
xCT delivery to the plasma membrane and/or a decrease in the rate of its removal from the plasma
membrane. First, we examined the rate of constitutive delivery of xCT to the plasma membrane in the
absence of H2O2 using the methods previously established to measure the rate of EEAC1, GAT and TfR
delivery (Fournier et al., 2004; Wang and Quick, 2005). Specifically, we treated U-138MG cells with a
membrane impermeable biotinylating reagent for increasing lengths of time at 37oC (trafficking
permissive conditions) which allows those proteins cycling to the membrane surface to be biotinylated.
Following purification of the biotinylated fraction and Western blot analysis, we compared the fraction of
biotinylated xCT at 37oC to the fraction of biotinylated xCT at 4oC (trafficking impermissive conditions).
We demonstrated that delivery of xCT is dependent on time (One-way ANOVA; F(3,12)=5.6, p=0.013),
with the proportion of xCT labeled at the cell surface doubling in approximately 30 min (Figure 4A). This
rate of trafficking of xCT to the plasma membrane is slightly slower than has been observed for EEAC1
and GAT which show doubling rates of 15 min and 5 min, respectively (Fournier et al., 2004; Wang and
Quick, 2005). We then used the same biotinylation technique to measure the effect of peroxide exposure
on the rate of xCT delivery to the plasma membrane. We discovered that a 10 min exposure to 0.3 mM
H2O2 leads to a modest, yet significant increase in the fraction of xCT that is biotinylated during this time
frame. Specifically, after 10 min, there is a 131 ± 9% increase in biotinylated xCT relative to the 4oC
control, but in the presence of 0.3 mM H2O2, there is a 160±13% increase in biotinylated xCT relative to
the 4oC control (t(6)=-3.57; p=0.012), suggesting that the increase in xCT membrane localization in the
presence of H2O2 is in part due to an increase in the delivery rate of xCT to the membrane (Figure 4B).
Since we observed an increase in the rate of delivery of xCT to the plasma membrane in the
presence of H2O2, we next sought to determine the effect of H2O2 on the recovery rate of xCT from the
plasma membrane using a reversible biotinylation assay. This method requires that most of the
biotinylating reagent can be stripped from the protein of interest efficiently using a reducing reagent.
Unfortunately, we were unable to strip more than 20 percent of the biotinylating reagent from the cell
surface xCT protein with fresh 50 mM GSH, 50 mM MesNA or 50 mM TCEP (data not shown), even
when the cells were kept at 4oC (conditions in which trafficking does not occur). Therefore, we used a
cell ELISA assay for measuring the internalization rate of xCT (Figure 4B) in the presence and in the
absence of H2O2. This method has been successfully used to measure internalization of AMPA receptor
subunits (Lin et al., 2000; H.-Y. Man et al., 2000), α-adrenergic receptors (Wang et al., 2007), and
epidermal growth factor receptors (Johns et al., 2002) in response to various external stimuli. Briefly, cell
surface xCT on U-138MG cells was labeled for one hour at 4oC (trafficking impermissive conditions)
using a primary antibody directed to an extracellular motif within xCT (goat). Baseline xCT cell surface
expression was then measured by applying a secondary antibody coupled to horseradish peroxidase and
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subsequent exposure to a chromogenic substrate. To measure internalization rates, cell surface xCT was
measured after rewarming the cells to 37oC (trafficking permissive conditions) for 15 min or 30 min after
pre-labeling cell surface xCT antibody for one hour at 4oC. The fraction of xCT measured on the
membrane in rewarmed samples relative to that measured in samples which were not rewarmed to 37oC is
reported in Figure 4C. We demonstrated that xCT undergoes relatively rapid internalization from the
membrane at 37oC such that 30 min after cell surface labeling of xCT, only 48% of the labeled xCT
remains on the membrane (Figure 4C). When the cells were rewarmed to 37oC for 30 min in the presence
of 0.3 mM H2O2, however, the internalization rate of xCT decreased significantly, with 82% of the labeled
cell surface xCT remaining on the membrane (t(22)= -4.28, p<0.001). Thus, while xCT undergoes
relatively rapid internalization from the membrane under basal conditions, the rate decreases significantly
following H2O2 exposure, contributing to an increase cell surface expression of xCT on the plasma
membrane.
3.4 Subcellular localization of endogenously expressed xCT in cultured U-138MG cells
Since the trafficking dynamics of xCT appears to be altered in response to H2O2, we hypothesized
that a significant component of xCT would be localized to early endosomes, critical components of the
membrane protein trafficking system. Therefore, we used immunocytochemistry to test the hypothesis
that a fraction of xCT is localized to this pool of vesicles. We observed a fraction of intracellular xCT in
vesicle-like structures which co-localize with the EEA1 in confluent U-138MG cells (Figure 5),
suggesting that xCT does undergo regulated and constitutive trafficking through the endocytic pathway.
In addition to studying the localization of xCT in respect to EEA1, we were interested in
examining the co-localization of xCT with 4F2HC. Our biotinylation data suggested that 4F2HC does not
exhibit the same H2O2-induced increase in cell surface expression as xCT (Figure 3B, C). Therefore, we
examined the co-localization of xCT and 4F2HC in U-138MG cells before and after a 10 min exposure to
0.3 mM H2O2 (Figure 6A). Overall, there is no effect of H2O2 on the observed co-localization (Pearson
coefficient) of xCT and 4F2HC in within cells (Figure 6B). However, in vehicle-treated cells, much of the
4F2HC on the membrane and within the cytoplasm does not co-localize with xCT. Instead, the majority
of the xCT signal is observed within the intracellular compartment, co-localized with 4F2HC (Figure 6B).
This observation is consistent with our hypothesis that only a fraction of the pool of 4F2HC co-localizes
with xCT. Following H2O2 treatment, there is a greater co-localization of 4F2HC and xCT on the
membrane as indicated by an increase in the mean Pearson coefficient around the periphery of the cell
(t(10)=-2.86, p=0.017; Figure 6C). However, there still remains a pool of 4F2HC localized to the
membrane that is not co-localized with xCT. Thus, these data support our earlier suggestion that a small
fraction of the total pool of 4F2HC may traffic to the membrane with xCT in response to H2O2 treatment.
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3.5 Functional Significance of H2O2 Regulation of System xcSeveral studies have demonstrated that System xc- plays an important role in the regulation of
intracellular glutathione levels (Cho and Bannai, 1990; Chung et al., 2005; Kato et al., 1992b; Mysona et
al., 2009; Ogunrinu and Sontheimer, 2010; Pereira and Oliveira, 1997). In addition, glutathione
peroxidase has been suggested to be the most important mechanism for detoxification of H2O2 in glioma
cells (Dringen et al., 2005). Since this enzyme couples the oxidation of glutathione to the reduction of
H2O2 to water, the maintenance of glutathione levels is especially important for the detoxification of H2O2.
Thus, we hypothesized that System xc- may play a significant role in the maintenance of cellular
glutathione levels following an acute exposure to H2O2, since under these conditions astrocytes rapidly
export glutathione for use by neurons (Wang and Cynader, 2000). To begin to test this hypothesis, we
measured total cellular glutathione levels for two hours following a 10 min exposure to 0.3 mM H2O2
which has previously been shown to result in the release of intracellular glutathione into the extracellular
medium (Hirrlinger et al., 2001; Hohnholt and Dringen, 2014). As expected, H2O2 treatment resulted in a
rapid decrease in total cellular glutathione which recovered to baseline within 60 min of the removal of the
H2O2 from the extracellular medium (Figure 7A). Intracellular levels of H2O2, however, recovered much
more rapidly, nearing baseline levels within a minute of washing the H2O2 from the cell culture medium
(Figure 7B).
Since we originally observed that H2O2-induced changes in System xc- transporter activity peaked
at 30 min, approximately 10 minutes after glutathione levels in the cell reached their lowest level, we
hypothesized that the trafficking of xCT may be regulated by either the glutathione or H2O2 concentration
within the cell. To begin to address this question, we measured the changes in xCT cell surface
expression over time following a 10 min exposure to 0.3 mM H2O2. We found the H2O2-induced increase
in xCT membrane expression (Figure 7C) mirrors the time course of System xc- transporter activity
(Figure 2B), and lags slightly behind the recovery of intracellular glutathione levels. Specifically, both
xCT cell surface expression and System xc- transport activity reach a maximum approximately 30 min
after the exposure to H2O2, and do not return to baseline until 120 min (Figure 4). While these data do not
directly address the question as to whether the redistribution of System xc- to the plasma membrane is
necessary to observe the recovery of glutathione levels, the fact that the trafficking event occurs on the
same time scale as the observed changes in cellular glutathione levels suggests that the trafficking event
does play an important role in the acute regulation of cellular glutathione.
Finally, since we hypothesized that maintenance of cellular glutathione levels is important for
protection from oxidative-stress induced cell death, we also assessed the effect of a ten-minute exposure to
H2O2 on glial cell death. U-138MG cells were grown to 95% confluence and treated with vehicle or 0.3
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mM H2O2 for 10 min and washed three times with PBS. Twenty-four hours later, the cells were assessed
for cell death using the Trypan Blue assay. We observed no difference in the cell survival between
vehicle- (89.6% ± 10.1%) and H2O2-treated (85.6% ± 12.0%) cells (t(32)=1.062, p=0.296, n=17).
3.6 Recombinant System xc- expressed in COS-7 cells is also regulated by H2O2
System xc- is highly expressed by human glioma cells (Ye et al., 1999) and is readily induced in
many cell types in culture (Devés and Boyd, 2000). Therefore, we wanted to verify that the regulation of
endogenously expressed System xc- by H2O2 is not unique to human glioma cells. Therefore, we
transiently expressed recombinant myc-xCT and HA-4F2HC in COS-7 cells. We chose this cell line
because it does not express xCT endogenously (Figure 1B). Similar to confluent U-138MG cells, we
observed that a 10 min exposure of myc-xCT/HA-4F2HC transfected COS-7 cells to 0.3 mM H2O2
resulted in a 2.5-fold increase in cell surface expression of myc-xCT (t(6) = -2.618, p=0.04) (Figure 8A,
B). In addition, we observed a 1.6-fold increase in HA-4F2HC cell surface expression following H2O2
exposure (t(6)= -1.355, p=0.22). While this increase was not statistically significant, these data are
consistent with our immunocytochemical analysis (Figure 6) which suggests that xCT:4F2HC
heterodimers likely traffic to the membrane in response to oxidants. Finally, these data suggest that the
regulation of System xc- by H2O2 is not limited to human glioma cells.
4.0 Discussion
Here we report that the activity of endogenously expressed System xc- is acutely regulated by
exogenous application of H2O2 in human glioma cells. Specifically, exposure of cultured human glioma
cells to H2O2 leads to a three-fold increase in System xc- activity which is accompanied by a rapid increase
in cell surface expression of System xc-. In support of our current findings, Mysona and colleagues
(Mysona et al., 2009) previously reported that a six hour exposure of mouse retinal Muller glial cells to
oxidative stress through the exogenous application of xanthine and xanthine oxidase led to an 89%
increase in System xc- activity. The increase in activity was the result of a 2.4-fold increase in expression
of the mRNA which encodes xCT and a 3.9-fold increase in the cell surface expression of xCT expressed
in retinal Muller cells. Similarly, Ogunrinu and colleagues demonstrated that growing D54-MG glioma
cells under hypoxic conditions led to a 4-fold increase in the intracellular concentration of reactive oxygen
species within 48 hours which was also accompanied by a 3.5-fold increase in cell surface expression of
xCT , a 1.5-fold increase in System xc- activity, and an increase in glutathione utilization (Ogunrinu and
Sontheimer, 2010). Similar to what we have observed here, the total expression of xCT was not changed
during the hypoxic exposure. While these studies were not focused on the acute regulation of System xc-
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trafficking by oxidants, they provide further evidence that oxidative stress regulates the cell surface
expression of System xc-.
The acute modulation of cell surface expression of many transporters is a common mechanism of
functional regulation (for review see Maxfield and McGraw, 2004; Hou and Pessin, 2007; Santos et al.,
2009). One of the best studied examples is the regulation of the trafficking of GLUT4 by insulin (Hou
and Pessin, 2007). In muscle and adipose tissue, insulin triggers the movement of intracellularly localized
GLUT4 to the plasma membrane, thus facilitating the uptake of glucose into cells when glucose levels are
high. In kidney epithelial cells, aldosterone and vasopressin increase the cell surface expression of
epithelial sodium channel (ENaC) allowing for maintenance of proper sodium balance, blood volume and
blood pressure (Butterworth et al., 2009). In neurons and glia, neurotransmitter transporters exhibit
reduced cell surface expression following activation of protein kinase C (Melikian, 2004; Robinson,
2006). In each of these examples, the transporters are observed in endosomal compartments within the
cell, and the rates of exocytosis and internalization of the transporter are altered. We have shown that
System xc- is localized to early endosomes within glioma cells and that the increase in cell surface
expression is a result of both an increase in the rate of delivery of xCT to the plasma membrane and a
decrease in the rate of xCT internalization from the plasma membrane.
The fact that the time-course for the H2O2-triggered increase in transporter activity and cell
surface expression correlates with changes in total cellular glutathione levels suggests that the process
described here may be a component of a critical feedback mechanism which allows cells to rapidly
respond to oxidative insults and increase cellular glutathione levels. Peroxides are produced as a result of
aerobic metabolism in all cell types (for review see Dringen et al., 2005). Specifically, superoxide
produced during mitochondrial respiration is continuously detoxified to H2O2 through the action of the
enzyme superoxide dismutase. Once formed, H2O2 must be rapidly removed from cells to prevent metalcatalyzed formation of highly reactive hydroxyl radicals that can cause irreversible covalent modification
of DNA, lipids, and proteins. H2O2 is enzymatically degraded by the action of two enzymes, catalase and
glutathione peroxidase (GPx). Since GPx couples the reduction of H2O2 to H2O to the oxidation of
glutathione, loss of cellular glutathione can rapidly lead to increases in cellular H2O2 (Dringen et al.,
2005).
Given that the brain is the most metabolically active tissue, there is increased need for
maintenance of glutathione levels for proper regulation of H2O2 (Dringen et al., 2005). A microdialysis
study in freely moving rats established that the baseline concentration of H2O2 in the extracellular fluid in
the striatum is about 25 µM (Hyslop et al., 1995). However, within 20 min after a brief ischemic episode
(30 min), the extracellular H2O2 concentration increases to150 µM before recovering to baseline levels
one hour later. Given that the EC50 we observed for H2O2-induced increase in System xc- activity is at
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least-two fold lower (65 µM), suggests that the regulation of System xc- cell surface trafficking is
physiologically relevant, and may serve to increase cellular reserves of cystine for glutathione synthesis.
In support of this hypothesis, Soria and colleagues recently observed a large increase in System xc- activity
in rodent cerebral cortex organotypic cultures within 12 minutes of onset of a 45 min oxygen glucose
deprivation (Soria et al., 2014). Using PET imaging, the same group also demonstrated that System xcactivity increases in vivo in the rat striatum 1.5-fold within five minutes of reperfusion following two
hours of transient focal ischemia. System xc- activity continued to stay elevated for at least five hours
following reperfusion. While the investigators were unable to measure System xc- activity in the rats
during the transient ischemic event, our data suggests that the upregulation of the transporter activity may
actually occur during the onset of the ischemic event when oxidant levels rise rapidly in the brain.
Collectively, the data from these studies are consistent with the hypothesis that ischemic events lead to
rapid increases in H2O2 levels which trigger an increase in cell-surface expression of System xc-.
Whether the H2O2-mediated increase in cell surface expression of System xc- is actually driven by
H2O2 or by the immediate drop in intracellular glutathione that accompanies the oxidative stimulus cannot
be directly determined from this study. Similarly, we cannot ascertain from our data whether it is
intracellular H2O2 or extracellular H2O2 which triggers the trafficking of xCT. We did demonstrate that
H2O2 levels rise intracellularly after we applied it extracellularly, but we did not whether it was
intracellular or extracellular H2O2 (or both) that triggered the translocation. Similar doses of exogenously
applied H2O2 have previously been shown to increase the cell surface localization of GLUT4 in adipocytes
(Mahadev et al., 2001) and cardiac myocytes (Horie et al., 2008) and ENaC in alveolar epithelial cells
(Downs et al., 2013). H2O2 is also known to activate several cellular signaling cascades (Truong and
Carroll, 2013) including, but not limited to, phosphoinositol-3-kinase(PI3K)/Akt Kinase, AMP-activated
protein kinase (AMPKinase), mitogen activated protein kinase (MAPK), and several Receptor Tyrosine
Kinases (RTKs), many of which have been shown to regulate the cell surface expression of several
transporters and proteins. Thus, it is plausible that H2O2 triggers the activation of one or more signaling
pathways leading to a transient increase in cell surface expression of xCT in a manner analogous to that
observed for GLUT4 and ENaC. However, we also observed the time course of increased System xcactivation and xCT cell surface expression lags slightly behind the rate of recovery of intracellular
glutathione levels, while intracellular H2O2 levels returned closer to baseline within min following wash of
H2O2 from the extracellular compartment. Therefore, it is plausible that the trafficking of xCT may be
regulated by intracellular glutathione levels itself.
Despite the fact that we observed a significant increase in the cell surface expression of xCT in the
presence of H2O2, we were not able to detect a comparable change in the cell surface expression of
endogenously expressed 4F2HC in cultured glioma cells. Previous studies have suggested that 4F2HC

18

regulates the trafficking of the light chain proteins of the HAAT family, thus, we expected to observe a
shift in the cell surface expression of 4F2HC during H2O2 exposure (Verrey et al., 2004). Instead, we
observed that the majority of 4F2HC was found within the intracellular compartment, with no statistically
significant increase following H2O2 exposure. Given that 4F2HC forms dimers with multiple HAAT
protein light chains and β-integrins (Cantor and Ginsberg, 2012; Devés and Boyd, 2000), the absence of
an observed shift of 4F2HC to the membrane in response to H2O2 does not specifically demonstrate that
xCT traffics independently of 4F2HC under these conditions. It may be that our membrane biotinylation
assay is not sensitive enough to detect the fraction of the total amount of 4F2HC that actually shifts to the
membrane in response to H2O2, given that only a small fraction of 4F2HC is expected to be bound to and
trafficking with xCT. This possibility is strengthened by our observations that 1) a significant component
of the intracellular 4F2HC immunoreactivity we observed in human glioma cultures did not co-localize
with xCT in both control and H2O2 conditions (Figure 6B) and 2) recombinant HA-4F2HC expressed in
COS-7 cells showed a greater tendency to traffic to the membrane with myc-xCT in response to H2O2
(Figure 7A, B). However, these data do suggest that the H2O2-mediated increase in xCT cell surface
expression is a result of inherent regulation of the xCT protein, and not 4F2HC.
The fact that we have observed acute oxidant-mediated regulation of endogenously expressed
System xc- in U-138MG cells and recombinant myc-xCT and HA-4F2HC expressed in COS-7 cells
suggests that this may be a universal defense mechanism for rapid manipulation of glutathione levels in
response to oxidative insult. The chronic regulation of System xc- by oxidants and glutathione levels has
been studied in numerous cell types including activated macrophages, microglia, fibroblasts, cultured
neurons, astrocytes (for review see Bridges et al., 2012), and these studies have demonstrated that xCT is
transcriptionally activated under conditions of oxidative stress leading to a 2-3 fold increase in xCT
expression level. We now suggest that xCT will also exhibit a greater cell surface localization under these
same conditions, thus leading to additional stimulation in System xc- activity beyond that achieved by an
increase in xCT synthesis alone.
The increased capacity for glutathione production in astrocytes in response to oxidative stress also
has significant implications for neuronal survival given the central role that astrocytes play in regulating
neuronal glutathione levels (For review, see McBean, 2017). Unlike astrocytes, neurons do not rely on
System xc- for the import of cystine to supply a source of cysteine for glutathione production. Instead,
neurons directly import cysteine through the excitatory amino acid carrier-1. The source of the cysteine,
however, is astrocytic glutathione, which is maintained in relatively high concentrations (up to 8 mM).
Specifically, astrocytes export glutathione through the multidrug resistance protein-1 where it is degraded
by γ-glutamyl transpeptidase and neuronal dipeptidase into γ-glutamate, cysteine and glycine. The
cysteine and glycine are imported into neurons and used for glutathione synthesis, while the γ-glutamate is

19

recycled back into astrocytes. Thus, under conditions of oxidative stress, glutathione export from
astrocytes increases, as well as the demand for glutathione production to re-establish baseline glutathione
levels. Therefore, our observations that System xc- exhibits increased activity immediately in response to
H2O2 exposure and glutathione export in astrocytoma, suggests that the increased capacity for cystine
uptake and glutathione production in astrocytes may be important for both astrocytic and neuronal
oxidative balance.
While an increase in System xc- -mediated cystine uptake likely helps to ameliorate oxidative stress,
it is important to note that the associated obligatory upsurge in glutamate release by the transporter will
likely have a significant impact on extracellular glutamate levels and neighboring neurons. Since, System
xc- contributes to 60% of the total extracellular glutamatergic pool in the brain (D. A. Baker et al., 2002;
David A Baker et al., 2002), it is not surprising increases in System xc- activity are associated with 1)
activation of extra-synaptic metabotropic glutamate receptors which regulate vesicular neurotransmitters
release, 2) changes in the induction of long-term potentiation and long-term depression, and 3) alterations
in synaptic strength (D. A. Baker et al., 2002; Moran et al., 2005, 2003; Moussawi et al., 2011, 2009). In
fact, Fogal and colleagues (Fogal et al., 2007) demonstrated that hypoxia induces excitotoxicity in mixed
cortical-cell cultures in a System xc- -dependent manner. Thus, while oxidant-mediated increases in
System xc- cell surface expression might function to combat the developing oxidative stress associated
with ischemic events, it likely will contribute to a rise in glutamate release from astrocytes. Such
upregulation of System xc- is observed in human gliomas, resulting in epileptic seizures, excitotoxic cell
death of neurons, and rapid expansion of the tumor (Buckingham et al., 2011; Savaskan et al., 2008; Ye et
al., 1999).
5.0 Conclusions:
In summary, this is the first report that the cell surface expression of System xc- can be acutely
regulated by oxidants. This effect is dose dependent with an EC50 of 65 µM and persists for nearly 60 min
following the removal of the stimulus. In addition, the oxidant-induced change in activity and cell
surface expression is consistent with the time-course of cellular glutathione recovery, suggesting we have
identified a novel positive feed-back loop wherein redox stress leads to an upregulation of System xcactivity and an increase in available cystine (and cysteine) for glutathione synthesis. Given the unique
role of System xc- in regulating both the redox environment and extracellular glutamate levels and its
implication in the pathogenesis of stroke, addiction, schizophrenia, macular degeneration, Alzheimer’s
Disease and Parksinson’s Disease (Bridges et al., 2012), it is imperative that future studies are aimed at
developing a more comprehensive understanding of the processes which regulate System xc- trafficking.
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Figure Captions
Figure 1. Characterization of xCT antibody for use in western blot and immunocytochemical
analysis. A. Control U-138MG or DEM-treated U-138MG cells were immunoblotted for xCT and actin
(loading control). Note a 40 kDa band for xCT under control conditions (lane 1) and 2 bands at 27 kDa
and 40 kDa following a 24-hour treatment with DEM. B and C. COS-7 cells transfected with either the
myc-xCT pCMV-3Tag-2A construct (4 µg or 2 µg of DNA) or the empty pCMV vector (4 µg) were
immunoblotted for xCT and anti-actin (B) or myc (C) N.S. labels a non-specific band that is visualized
with the anti-myc antibody only in the membrane fraction (M) but not in the intracellular fraction (I) when
performing cell surface biotinylation assays. D. COS-7 cells transfected with myc-xCT pCMV-3TAG2A immunostained for c-myc (red) and xCT with the novel anti-xCT antibody (green). Pearson
correlation of 0.972.
Figure 2. H2O2 triggers an increase in System xc- activity in cultured U-138MG cells. A. Mean
uptake (± S.E., n=12) of 35S-L-cystine (20 µM) for 10 min in U-138MG cells treated with either 0.3 mM
H2O2 or vehicle for 10 min. CPG (0.2 mM) was used to identify System xc--specific cystine uptake
(*p=0.001). B. Dose dependence of the effect of H2O2. Mean specific (± S.E., n=6) 35S-L-cystine
transport activity cystine (25 µM) measured 10 min following exposure to various concentrations of H2O2
The data were fit to the equation (y=Bottom + (Top-Bottom)/(1+10(LogEC50-x)); R2=.9945) giving an EC50
for H2O2 of 65 µM. C. Mean specific 35S-L-cystine transport activity (± S.E., n=4) measured at various
time points following the 10 min exposure of cells to 0.3 mM H2O2 (indicated by black bar). There was a
significant effect of time on transport activity (F(6,29)=23.2, p<0.001, *indicates data significantly
different than time 0 p<0.05). D. Steady state kinetic analysis of cystine transport following a 10 min
exposure to 0.3 mM H2O2 or vehicle (control) for 10 min. The data are fit to the hyperbolic function
uptake = Vmax * [cystine]/(Km + [cystine]). Under control conditions Vmax = 297 pmols/mg protein and
Km=100 µM. After a 10 min exposure to 3 mM H2O2, Vmax = 513 pmols/mg protein/min and Km= 117
µM. (n=6 ± S.E.).
Figure 3. Trafficking of endogenously expressed xCT and 4F2HC in U-138MG cells in response to
H2O2 exposure. Biotinylation assays were used to label cell surface xCT (A) and 4F2HC (B) in cultured
U-138MG cells exposed to either 0.3 mM H2O2 or vehicle for 10 min. xCT in lysate (L), intracellular (I)
and membrane (M) fractions were visualized by western blot. The integrity of the biotinylation assay was
determined by probing the same blots with anti-actin. The mean percentage of xCT and 4F2HC found on
the cell surface is plotted (n=8; *p=0.001) in C.
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Figure 4. Effect of H2O2 on constitutive delivery and recovery of xCT from the plasma membrane.
A. Mean rate of constitutive delivery of endogenously expressed xCT to the plasma membrane was
measured over time. Data are presented as percentage of xCT immunoreactivty observed in the
biotinylated (B), non-biotinylated (NB) or total xCT in cell lysate (T) under trafficking-impermissive
conditions (4oC). There is a significant effect of time on the percent of xCT that is found in the
biotinylated fraction, i.e. there is an effect of time on the delivery of xCT to the membrane (F(3,12)=5.56,
p=0.013, n=4 ± S.E). B. Mean fraction of biotinylated xCT following a 10 min exposure of U-138MG
cells to vehicle (control) or 0.3 mM H2O2 (n=4 ± S.E; *p=0.01). C. Cell surface internalization rates of
endogenously expressed xCT were measured using a colorimetric cell ELISA-based assay. Cell surface
xCT was labeled in cultured U-138MG cells for one hour at 4oC with a goat anti-xCT antibody directed to
an epitope in the extracellular region of the protein. The total labeled xCT was measured after warming
the cells to 37oC for either 15 min or 30 min in the presence and absence of 0.3 mM H2O2 and compared
to the total labeled xCT in samples not warmed to 37oC (t=0). Data are expressed as percent of total
surface expression at t=0 (n=12 ± S.E; **p=0.001).
Figure 5. Subcellular localization of endogenously expressed xCT in U-138MG cells. xCT (green)
and EEA-1 (red) were visualized in cultured U-138MG cells. Co-localization is shown in the third panel
(merge) and the area within the white box is shown in the fourth panel.
Figure 6. H2O2-induced changes in subcellular localization of endogenously expressed xCT and
4F2HC in U-138MG cells. A. xCT (green) and 4F2HC (red) were visualized in cultured U-138MG cells
treated with either 0.3 mM H2O2 or vehicle (control). Co-localization is shown in the third panel (merge)
and the Pearson coefficients for the cell is given in white. The area within the white box is shown in the
fourth panel and white arrows indicate 4F2HC immunostaining (red) which does not co-localize with xCT
immunostaining (green). B. The green and red fluorescence intensity is plotted as a function of pixel
number along a cross-section (indicated by the yellow arrows in A) of control and H2O2-treated cells. C.
Pearson coefficients were measured for six cells from three separate experiments under both control and
H2O2 conditions. In addition, the Pearson coefficients were also measured for the periphery (cell
membrane) by identifying a ROI 20-pixels in width along the outer edge of the cells (*p=0.017).
Figure 7. Time course of changes in total cellular glutathione, xCT cell surface expression and
intracellular H2O2 levels following a 10 min H2O2 exposure A. Mean total cellular glutathione levels
(n=6 ± S.E) after a 10 min exposure to either 0.3 mM H2O2 (indicated by black bar) or vehicle (control)
are plotted as a function of time. * Indicates those data which are significantly different from control
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p<0.05. B. Mean intracellular H2O2 levels (n=24 ± S.E) in U13MG were plotted as a function of time
following either a 10 min exposure to 0.3 mM H2O2 (indicated by black bar) or vehicle. C. Mean percent
of xCT (n=4 ± S.E) localized to the plasma membrane is plotted over time following a 10 min exposure to
0.3 mM H2O2 (indicated by black bar). Percent xCT on membrane is calculated by dividing the
immunoreactivity measured in the membrane (biotinylated) fraction by the total xCT immunoreactivity
(intracellular (I) + membrane (M)). *Indicates those data which are significantly different than time 0,
p<0.05.
Figure 8. H2O2-induced trafficking of transiently-expressed, recombinant myc-xCT and HA-4F2HC
in COS-7 cells. A. myc-xCT expressed in COS-7 cells exhibits a shift from the intracellular (I)
compartment to the membrane (M). The trafficking of HA-4F2HC is less pronounced. N.S. labels the
non-specific band that is visible only in the intracellular compartment. B. H2O2 exposure has a significant
effect on mean relative membrane expression of myc-xCT, but not HA-4F2HC. n=4, *p<0.05
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